New catheter aims to improve repeat ablation for AF patients

NCT ID NCT07390214

Recruiting now Disease control Sponsor: Cardioangiologisches Centrum Bethanien Source: ClinicalTrials.gov ↗

First seen Feb 05, 2026 · Last updated May 25, 2026 · Updated 14 times

Summary

This study tests a new type of catheter (AFFERA) against a standard one for a repeat heart procedure called ablation in 200 people with symptomatic atrial fibrillation (AF). The goal is to see if the new catheter can better block faulty electrical signals in the heart. Participants must have had one prior ablation and still have symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION - SYMPTOMATIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cardioangiologisches Centrum Bethanien, Frankfurt am Main, 60431
RECRUITING

Frankfurt am Main, Hesse, 60431, Germany

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ATRIAL FIBRILLATION - SYMPTOMATIC